Intricon introduces new patent-pending APT Open in-the-canal hearing aid

IntriCon Corporation, a designer, developer, manufacturer and distributor of body-worn devices, today announced that it has launched its all-new, patent-pending APT™ Open in-the-canal (ITC) hearing aid. Previewed at the European Hearing Aid Acousticians conference in October 2010, APT is a complete, technically advanced hearing aid.

"IntriCon has a track record of developing hearing aids that bring proprietary enhancements to the marketplace—the APT continues that tradition," said Mark S. Gorder, president and chief executive officer of IntriCon. "According to the Better Hearing Institute, an estimated 31.5 million people suffer from hearing difficulty. What's troubling is that many of these people are reluctant to seek help.

"Research has shown that there are considerable negative social, psychological, cognitive and health effects associated with untreated hearing loss. APT offers an effective means to address this condition—it's a technology-driven device that delivers the latest advances in hearing health."

APT is powered by IntriCon's Overtus™ DSP amplifier and features the company's Reliant CLEAR™ adaptive feedback canceller and the AcousTAP ™ acoustic push button. Reliant CLEAR is the latest in feedback cancellation, offering more added stable gain and faster reaction time. The AcousTAP Switch changes user programs when the ear is patted and not the hearing aid—this eliminates the physical push button, saving size and cost.

APT's elegant design is so small (smaller than a dime) that it does not occlude a person's ear canal and the product's replaceable wax guard system enhances the device's robust mechanical design. Additionally, its patent-pending retention features allow the unit to be easily converted to either a left- or right-ear device. These unique features create stable, effective amplification, occlusion-free comfort and easy integration into existing fitting systems.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Prenatal bilingual exposure boosts babies' speech sensitivity, study finds